» Articles » PMID: 36819366

Osteogenesis Imperfecta: A Case Series and Literature Review

Abstract

Osteogenesis imperfecta (OI) is a hereditary disease of connective tissue characterized by the loss of bone density and mass, which increases the fragility of the bones, thus presenting multiple fractures throughout the years followed by bone deformity and articular instability. This condition has various clinical presentations. We present four cases of OI, one case with type I, two cases with type II, and one case with type III. The clinical diagnosis in most of the cases was clinical; only one of them was confirmed with genomic sequence. The treatment of these cases was based on medication, orthopedic surgery, and recovery and physical therapy. The evolution was torpid in these cases but with prolonged life expectancy despite the severity and type of OI. It is important to highlight that the patients did not have a neurocognitive compromise. Early diagnosis and multidisciplinary medical management are crucial in obtaining better outcomes for this disease, improving the quality of life, and avoiding complications.

Citing Articles

A Successful Laparoscopic Appendectomy for an Adult Male Patient with Osteogenesis Imperfecta.

Farid M, Baz A, Hemdan M, Abdelhamid T, Ebrahim D, Fayed F Eur J Case Rep Intern Med. 2024; 11(9):004738.

PMID: 39247237 PMC: 11379103. DOI: 10.12890/2024_004738.


Management of Combined Fracture Neck of Femur and Femoral Deformity in Osteogenesis Imperfecta Patient: A Case Report.

Elbaseet H, Ibrahim A, Abol Oyoun N, Abdelzaher M, Khaled M Strategies Trauma Limb Reconstr. 2024; 19(1):56-59.

PMID: 38752190 PMC: 11091891. DOI: 10.5005/jp-journals-10080-1611.

References
1.
Roughley P, Rauch F, Glorieux F . Osteogenesis imperfecta--clinical and molecular diversity. Eur Cell Mater. 2003; 5:41-7. DOI: 10.22203/ecm.v005a04. View

2.
Forlino A, Cabral W, Barnes A, Marini J . New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011; 7(9):540-57. PMC: 3443407. DOI: 10.1038/nrendo.2011.81. View

3.
Shi C, Zhang Y, Yuan W . Efficacy of Bisphosphonates on Bone Mineral Density and Fracture Rate in Patients With Osteogenesis Imperfecta: A Systematic Review and Meta-analysis. Am J Ther. 2015; 23(3):e894-904. DOI: 10.1097/MJT.0000000000000236. View

4.
Valadares E, Carneiro T, Santos P, Oliveira A, Zabel B . What is new in genetics and osteogenesis imperfecta classification?. J Pediatr (Rio J). 2014; 90(6):536-41. DOI: 10.1016/j.jped.2014.05.003. View

5.
Kendler D, Marin F, Zerbini C, Russo L, Greenspan S, Zikan V . Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2017; 391(10117):230-240. DOI: 10.1016/S0140-6736(17)32137-2. View